{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:29Z","timestamp":1759451909195,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Korea Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.vaccine.2021.02.076","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T21:02:52Z","timestamp":1615410172000},"page":"1929-1932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study"],"prefix":"10.1016","volume":"39","author":[{"given":"Byung Ok","family":"Kwak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Se","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Wook","family":"Eun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwang Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.02.076_b0005","series-title":"Plotkin\u2019s Vaccines","first-page":"511","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2018"},{"key":"10.1016\/j.vaccine.2021.02.076_b0010","series-title":"(Department of Health, London, Great Britain) Immunisation against infectious disease","first-page":"201","author":"Salisbury","year":"2006"},{"key":"10.1016\/j.vaccine.2021.02.076_b0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMra030476","article-title":"Flavivirus encephalitis","volume":"3515","author":"Solomon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.02.076_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2021.02.076_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past, present, and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0030","unstructured":"The Korean Pediatric Society. Japanese encephalitis vaccines. In: Kim JH editors. Immunization Guideline. 9th ed. Seoul: The Korean Pediatric Society; 2018, p. 186-202."},{"key":"10.1016\/j.vaccine.2021.02.076_b0035","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/INF.0000000000000967","article-title":"Immunogenicity and safety of a booster dose of a live attenuated Japanese encephalitis chimeric vaccine given 1 year after primary immunization in healthy children in the Republic of Korea","volume":"35","author":"Kim","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"61","key":"10.1016\/j.vaccine.2021.02.076_b0040","first-page":"333","article-title":"to 2004","volume":"2008","author":"Arai","year":"1982","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003030","article-title":"The incidence of Japanese encephalitis in Taiwan - a population-based study","volume":"8","author":"Hsu","year":"2014","journal-title":"PLos Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14776\/kjpid.2013.20.3.131","article-title":"Immunogenicity and protective effectiveness of Japanese encephalitis vaccine: a prospective multicenter cohort study","volume":"20","author":"Kim","year":"2013","journal-title":"Korean J Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12879-014-0744-4","volume":"8","author":"Yun","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.vaccine.2018.01.075","volume":"36","author":"Yun","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.076_b0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis-within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.02.076_b0070","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.vaccine.2005.10.054","article-title":"The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine\u2013Results from 30 years experience in Taiwan","volume":"24","author":"Yang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.076_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14776\/kjpid.2001.8.2.150","article-title":"Persistency of neutralizing antibody to inactivated mouse brain derived Nakayama Japanese encephalitis vaccine and current observations of booster vaccination and adverse events","volume":"8","author":"Sohn","year":"2001","journal-title":"Korean J Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/tropej\/fmt043","article-title":"Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?","volume":"59","author":"Choi","year":"2013","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2021.02.076_b0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2017.11.023","article-title":"Systematic review of seroepidemiological studies on Japanese encephalitis in the Republic of Korea","volume":"67","author":"Choe","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0090","first-page":"83","article-title":"Recent epidemiological features of Japanese encephalitis in the Republic of Korea","volume":"6","author":"Kim","year":"1974","journal-title":"Korean J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0095","first-page":"21","article-title":"The distribution of hemagglutination inhibition antibody for Japanese encephalitis in residents of Seoul areas","volume":"19","author":"Kim","year":"1976","journal-title":"Choeshin Ui-hak"},{"key":"10.1016\/j.vaccine.2021.02.076_b0100","first-page":"75","article-title":"Serological study on Japanese encephalitis in Koreans and fowls, 1975","volume":"8","author":"Lee","year":"1976","journal-title":"Korean J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.076_b0105","first-page":"51","article-title":"The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus against the Koreas 1976","volume":"12","author":"Lee","year":"1977","journal-title":"J Korean Soc Microbiol"},{"key":"10.1016\/j.vaccine.2021.02.076_b0110","unstructured":"Lee CH, Ko KK. The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus in Korea (1977, 1978). Choeshin Ui-hak 1979; 113-9."},{"key":"10.1016\/j.vaccine.2021.02.076_b0115","first-page":"65","article-title":"The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus in Koreans 1979","volume":"10","author":"Lee","year":"1980","journal-title":"Korean J Virol"},{"key":"10.1016\/j.vaccine.2021.02.076_b0120","first-page":"1","article-title":"A hemagglutination inhibition antibody test for Japanese encephalitis virus among the Koreans, 1984\u20131985","volume":"15","author":"Lee","year":"1985","journal-title":"Korean J Virol"},{"key":"10.1016\/j.vaccine.2021.02.076_b0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines8020328","article-title":"Seroprevalence of neutralizing antibodies against Japanese encephalitis virus among adolescents and adults in Korea: a prospective multicenter study","volume":"8","author":"Kwak","year":"2020","journal-title":"Vaccines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100267X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100267X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:55:43Z","timestamp":1759402543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2100267X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0264410X2100267X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}